Niagen Bioscience (NAGE) EBIT Margin (2010 - 2026)
Niagen Bioscience's (NAGE) quarterly EBIT Margin came in at 5.01% in Q1 2026, down 1065.0% year-on-year from 0.52% in Q1 2025, and down 58.53% on a QoQ basis from 12.07% in Q4 2025.
Niagen Bioscience (NAGE) EBIT Margin (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 17 years of EBIT Margin data on file, last reported at 5.01% in Q1 2026.
- On a quarterly basis, EBIT Margin fell 1065.0% year-over-year to 5.01% in Q1 2026; TTM through Mar 2026 was 10.03%, a 223.0% decrease from a year earlier, with the FY2025 full-year figure at 12.58%, up 482.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 5.01%, down from 12.07% in the prior quarter.
- Over the last five years, EBIT Margin for NAGE reached as high as 24.42% in Q4 2024 and fell as low as 44.8% in Q1 2022.
- Historically, EBIT Margin has averaged 3.11% across 5 years, with a median of 1.13% in 2024.
- Across the five-year window, EBIT Margin jumped 3607 bps in 2023 and plunged 1234 bps in 2025, its largest moves.
- Year by year, EBIT Margin stood at 6.88% in 2022, then soared by 88 bps to 0.79% in 2023, then jumped by 3180 bps to 24.42% in 2024, then slumped by 51 bps to 12.07% in 2025, then sank by 59 bps to 5.01% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 5.01% in Q1 2026, 12.07% in Q4 2025, and 12.46% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 5.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.01% |
| Dec 31, 2025 | 12.07% |
| Sep 30, 2025 | 12.46% |
| Jun 30, 2025 | 10.24% |
| Mar 31, 2025 | 15.66% |
| Dec 31, 2024 | 24.42% |
| Sep 30, 2024 | 6.26% |
| Jun 30, 2024 | -1.13% |
| Mar 31, 2024 | -3.30% |
| Dec 31, 2023 | -0.79% |
| Sep 30, 2023 | -5.88% |
| Jun 30, 2023 | -11.40% |
| Mar 31, 2023 | -8.72% |
| Dec 31, 2022 | -6.88% |
| Sep 30, 2022 | -17.96% |
| Jun 30, 2022 | -38.17% |
| Mar 31, 2022 | -44.80% |
| Dec 31, 2021 | -29.93% |
| Sep 30, 2021 | -51.08% |
| Jun 30, 2021 | -31.38% |